@AlisonBFierce: Inovio Pharmaceuticals, a developer of synthetic vaccines, expanded its existing license agreement with UPenn. More | Follow @AlisonBFierce
> Vaccibody landed a €2 million ($2.54 million) grant from the Norwegian Research Council's BIA program to develop a therapeutic vaccine against precancerous lesions of the cervix. Story
> Inovio Pharmaceuticals ($INO) announced that its synthetic hepatitis B therapeutic vaccine generated strong T cell responses that eliminated targeted liver cells in mice. Release
> Researchers at the University of North Carolina and Vanderbilt University are taking a new live vaccine approach for SARS. Article
> A new study examines what it would cost to vaccinate girls against HPV in low-income countries. News
And Finally... Vietnam recalled Sanofi Pasteur's typhoid vaccine. Item